MicroRNA-483-5p Modulates the Expression of Cartilage-Related Genes in Human Chondrocytes through Down-Regulating TGF-β1 Expression

被引:17
|
作者
Xu, Ronghua [1 ,2 ]
Li, Jiayi [1 ]
Wei, Bo [1 ]
Huo, Weiling [2 ]
Wang, Liming [1 ]
机构
[1] Nanjing Med Univ, Nanjing Hosp 1, Dept Orthopaed Surg, 68 Changle Rd, Nanjing 210006, Jiangsu, Peoples R China
[2] Xuzhou Cent Hosp, Dept Orthopaed Surg, Xuzhou, Jiangsu, Peoples R China
关键词
cartilage repair; chondrocyte; miR-483-5p; osteoarthritis; TGF-beta; 1; GROWTH-FACTOR-BETA; RABBIT ARTICULAR CHONDROCYTES; MESENCHYMAL STEM-CELLS; TGF-BETA; IN-VITRO; II COLLAGEN; TRANSFORMING GROWTH-FACTOR-BETA-1; CHONDROGENIC DIFFERENTIATION; OSTEOARTHRITIS; MMP-13;
D O I
10.1620/tjem.243.41
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Transforming growth factor-beta 1 (TGF-beta 1) has been reported to improve chondrocytes phenotype and function. The expression levels of microRNA-483-5p (miR-483-5p), a potential regulator of TGF-beta signaling pathway, were elevated in chondrocytes of patients with osteoarthritis. In this study, we aimed to explore the role of miR-483-5p for the expression of cartilage-related genes in chondrocytes. Human chondrocytes were harvested from femoral condyle and tibial plateau of different donors (n = 10) following amputation due to sarcomas not involving the joint space. The expression levels of miR-483-5p and TGF-beta 1 mRNA were measured by qRT-PCR. Runt-related transcription factor 2 (RUNX2) is a transcription factor involved in chondrocyte differentiation, and type II collagen-degrading matrix metalloproteinasel3 (MMP13) contributes to cartilage degradation. qRT-PCR was also used to measure the levels of RUNX2 and MMP-13 mRNAs, as well as type II collagen alpha 1 (COL2A1) and aggrecan mRNAs. COL2A1 and aggrecan are major cartilage extracellular matrix proteins that are essential for normal cartilage function. The expression levels of miR-483-5p were significantly increased in chondrocytes from Passage 0 to 2, whereas the expression levels of TGF-beta 1 mRNA were marginally decreased. Passage 1 chondrocytes were employed for following experiments. MiR-483-5p overexpression reduced TGF-beta 1 expression, while miR-483-5p knockdown dramatically elevated TGF-p1 expression both at mRNA and protein levels. Further, miR-483-5p overexpression significantly decreased the levels of COL2A1 and aggrecan mRNAs, and increased those of RUNX2 and MMP13 mRNAs, by down-regulating TGF-beta 1 expression. These findings suggest that modulating miR-483-5p expression may contribute to maintaining the cartilage tissues.
引用
收藏
页码:41 / 48
页数:8
相关论文
共 24 条
  • [21] Inhibition of KCa3.1 suppresses TGF-β1 induced MCP-1 expression in human proximal tubular cells through Smad3, p38 and ERK1/2 signaling pathways
    Huang, Chunling
    Day, Margot L.
    Poronnik, Philip
    Pollock, Carol A.
    Chen, Xin-Ming
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2014, 47 : 1 - 10
  • [22] MicroRNA-146a-5p Attenuates Fibrosis-related Molecules in Irradiated and TGF-beta1-Treated Human Hepatic Stellate Cells by Regulating PTPRA-SRC Signaling
    Yuan, Bao-ying
    Chen, Yu-han
    Wu, Zhi-feng
    Zhuang, Yuan
    Chen, Gen-wen
    Zhang, Li
    Zhang, Hai-ge
    Cheng, Jason Chia-Hsien
    Lin, Qin
    Zeng, Zhao-chong
    RADIATION RESEARCH, 2019, 192 (06) : 621 - 629
  • [23] Long Noncoding RNA LINC01518 Modulates Proliferation and Migration in TGF-β1-Treated Human Tenon Capsule Fibroblast Cells Through the Regulation of hsa-miR-216b-5p
    Kong, Ning
    Bao, YaLi
    Zhao, Haixia
    Kang, Xin
    Tai, Xue
    Chen, Xu
    Guo, Wenqi
    Shen, Ying
    NEUROMOLECULAR MEDICINE, 2022, 24 (02) : 88 - 96
  • [24] Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer Cells
    Ko, Jen-Chung
    Syu, Jhan-Jhang
    Chen, Jyh-Cheng
    Wang, Tai-Jing
    Chang, Po-Yuan
    Chen, Chien-Yu
    Jian, Yun-Ting
    Jian, Yi-Jun
    Lin, Yun-Wei
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 117 (06) : 383 - 391